Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
70 hedge funds and large institutions have $236M invested in Flexion Therapeutics, Inc. in 2015 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 29 increasing their positions, 14 reducing their positions, and 9 closing their positions.
39,850% more call options, than puts
Call options by funds: $4.79M | Put options by funds: $12K
107% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 14
100% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 9
15% more funds holding
Funds holding: 61 → 70 (+9)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
17% less capital invested
Capital invested by funds: $285M → $236M (-$48.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$24.3M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$18.4M |
| 3 |
Jennison Associates
New York
|
+$17.3M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$9.49M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$5.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$25.8M |
| 2 |
KCM
Kingdon Capital Management
New York
|
-$5.45M |
| 3 |
VAM
Visium Asset Management
New York
|
-$3.46M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$3.12M |
| 5 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
-$1.15M |
FLXN Hedge Fund Activity: Q3 2015 in Review
70 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q3 2015, worth a combined $236M — down 17% from $285M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new FLXN positions and 9 closed out — a net gain of 9 holders — while 29 added to existing stakes and 14 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $24.3M. The largest seller was Novo Holdings A/S, cutting an estimated $25.8M.
- 70 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q3 2015, up from 61 in Q2 2015.
- Funds reported $236M of Flexion Therapeutics, Inc. stock for Q3 2015, down 17% quarter-over-quarter.
- 18 funds opened new Flexion Therapeutics, Inc. positions in Q3 2015 and 9 closed out, a net change of +9 holders.
- The largest Flexion Therapeutics, Inc. buyer in Q3 2015 was Wellington Management Group, an estimated $24.3M added.
- The largest Flexion Therapeutics, Inc. seller in Q3 2015 was Novo Holdings A/S, an estimated $25.8M sold.
Based on aggregated 13F filings for Q3 2015.